capsaicin has been researched along with Scleroderma, Systemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodecka, H; Glinska-Ferenz, M; Glinski, W; Kowalski, D | 1 |
| Barnes, PJ; Chung, KF; DuBois, R; Lalloo, UG; Lim, S | 1 |
| Glinska-Ferenz, M; Glinski, W; Pierozynska-Dubowska, M | 1 |
3 other study(ies) available for capsaicin and Scleroderma, Systemic
| Article | Year |
|---|---|
Neuropeptides in psoriasis: possible role of beta-endorphin in the pathomechanism of the disease.
Topics: beta-Endorphin; Capsaicin; Dermatitis, Atopic; Humans; Neuropeptides; Psoriasis; Scleroderma, Systemic; Skin; Substance P | 1994 |
Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease.
Topics: Bronchial Provocation Tests; Capsaicin; Case-Control Studies; Chronic Disease; Cough; Female; Humans; Isotonic Solutions; Lung Diseases, Interstitial; Male; Middle Aged; Reflex; Scleroderma, Systemic | 1998 |
Neurogenic inflammation induced by capsaicin in patients with psoriasis.
Topics: Administration, Cutaneous; Adult; Age Factors; Capsaicin; Dose-Response Relationship, Drug; Erythema; Forearm; Humans; Inflammation; Psoriasis; Scleroderma, Systemic; Skin; Substance P | 1991 |